Physician profile
Jaime Samluck
NPI 1770137440
$768.12
in general payments reported to CMS, 2019-2025
12 companies · $211 in 2025
The $211 reported for 2025 was more than what 76% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $124 · 2024: $434 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $343.79 | 2023-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $92.74 | 2023-2025 | Bexsero, Fluarix Quadrivalent, Pediarix |
| Sanofi Pasteur INC. | $56.92 | 2023-2025 | |
| Vertical Pharmaceuticals, LLC | $45.99 | 2024 | Relexxii |
| Cranial Technologies, INC | $45.12 | 2024 | Doc Band |
| Seqirus USA INC | $42.55 | 2024-2025 | Flucelvax |
| Phadia US INC. | $39.43 | 2024 | Immunocap |
| Corium, LLC | $31.79 | 2025 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $19.78 | 2024 | Flumist Quadrivalent |
| Lnhc, INC | $19.06 | 2025 | Zelsuvmi |
| Alexion Pharmaceuticals, INC. | $17.23 | 2024 | Koselugo |
| Medline Industries LP | $13.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Samluck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.